Jurgen J. Fütterer

ORCID: 0000-0001-6800-2879
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • MRI in cancer diagnosis
  • Urologic and reproductive health conditions
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced MRI Techniques and Applications
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pelvic floor disorders treatments
  • Advanced Radiotherapy Techniques
  • Ultrasound and Hyperthermia Applications
  • Renal cell carcinoma treatment
  • Pelvic and Acetabular Injuries
  • Anorectal Disease Treatments and Outcomes
  • Microbial Inactivation Methods
  • Urological Disorders and Treatments
  • Photoacoustic and Ultrasonic Imaging
  • Microfluidic and Bio-sensing Technologies
  • Medical Imaging Techniques and Applications
  • Cardiac Imaging and Diagnostics
  • Bladder and Urothelial Cancer Treatments
  • Advanced X-ray and CT Imaging
  • Colorectal Cancer Surgical Treatments
  • Renal and related cancers
  • Surgical Simulation and Training
  • Colorectal Cancer Screening and Detection

Radboud University Nijmegen
2016-2025

Radboud University Medical Center
2016-2025

University Medical Center
2015-2025

University of Twente
2014-2024

Radboud Institute for Molecular Life Sciences
2016-2023

Engineering Service Center und Handel (Germany)
2022

Elisabeth-TweeSteden Ziekenhuis
2022

Favaloro Foundation
2020

University Hospital and Clinics
2019

Erwin L. Hahn Institute for Magnetic Resonance Imaging
2016

The aim was to develop clinical guidelines for multi-parametric MRI of the prostate by a group experts from European Society Urogenital Radiology (ESUR), based on literature evidence and consensus expert opinion. True evidence-based could not be formulated, but compromise, reflected "minimal" "optimal" requirements has been made. scope these ESUR is promulgate high quality in acquisition evaluation with correct indications cancer across whole Europe eventually outside Europe. optimal...

10.1007/s00330-011-2377-y article EN cc-by-nc European Radiology 2012-02-09

Purpose: To prospectively determine the accuracies of T2-weighted magnetic resonance (MR) imaging, dynamic contrast material–enhanced MR and quantitative three-dimensional (3D) proton spectroscopic imaging entire prostate for cancer localization, with whole-mount histopathologic section findings as reference standard. Materials Methods: This study was approved by institutional review board, informed consent obtained from all patients. Thirty-four consecutive men a mean age 60 years...

10.1148/radiol.2412051866 article EN Radiology 2006-11-01

Undetected cancer in repeat transrectal ultrasound guided prostate biopsies patients with increased specific antigen greater than 4 ng/ml is a considerable concern. We investigated the tumor detection rate of suspicious regions on multimodal 3 Tesla magnetic resonance imaging and subsequent biopsy 68 men negative biopsies. compared results to those matched population. Also, we determined clinical significance detected tumors.A total 71 consecutive 2 or sessions underwent imaging. In this was...

10.1016/j.juro.2009.10.022 article EN The Journal of Urology 2009-12-16

Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active surveillance, and staging. The Imaging Reporting Data System (PI-RADS) helps provide a standardized probabilistic approach identifying clinically significant prostate cancer. Despite widespread use, the variability performance of across practices remains unknown. Purpose To estimate positive predictive value (PPV) PI-RADS detection high-grade cancer imaging centers. Materials Methods This...

10.1148/radiol.2020190646 article EN Radiology 2020-04-21

To prospectively compare image quality and accuracy of prostate cancer localization staging with body-array coil (BAC) versus endorectal (ERC) T2-weighted magnetic resonance (MR) imaging at 3 T, histopathologic findings as the reference standard.After institutional review board approval written informed consent, 46 men underwent 3-T MR a BAC (voxel size, 0.43 x 4.00 mm) an ERC 0.26 2.50 before radical prostatectomy. Four radiologists independently evaluated data sets obtained separately. Ten...

10.1148/radiol.2441060425 article EN Radiology 2007-05-10

To retrospectively compare transition zone (TZ) cancer detection and localization accuracy of 3-T T2-weighted magnetic resonance (MR) imaging with that multiparametric (MP) MR imaging, radical prostatectomy specimens as the reference standard.The informed consent requirement was waived by institutional review board. Inclusion criteria were specimen TZ larger than 0.5 cm(3) endorectal presurgery MP (T2-weighted diffusion-weighted [DW] apparent diffusion coefficient [ADC] maps [b < 1000...

10.1148/radiol.12120281 article EN Radiology 2012-11-11
J. Alfred Witjes Marek Babjuk Joaquim Bellmunt H.M. Bruins Theo M. de Reijke and 95 more Maria De Santis Silke Gillessen Nicholas D. James Steven MacLennan Juan Palou Tom Powles María J. Ribal Shahrokh F. Shariat Theodorus H. van der Kwast Évanguelos Xylinas Neeraj Agarwal Tom J.H. Arends Aristotle Bamias Alison Birtle Peter C. Black Bernard H. Bochner M. Bolla Joost L. Boormans Alberto Bossi Alberto Briganti Iris Brummelhuis Max M. Burger Daniel Castellano Richard Cathomas Arturo Chiti Ananya Choudhury Éva Compérat Simon J. Crabb Stéphane Culine Berardino De Bari Willem de Blok Pieter De Visschere Karel Decaestecker Konstantinos Dimitropoulos José L. Domínguez-Escrig Stefano Fanti Valérie Fonteyne Mark Frydenberg Jurgen J. Fütterer Georgios Gakis B. Geavlete Paolo Gontero Bernhard Grubmüller S. Hafeez Donna E. Hansel Arndt Hartmann Dickon Hayne Ann Henry Virginia Hernández Harry W. Herr Ken Herrmann Peter Hoskin J. Huguet Barbara Alicja Jereczek‐Fossa Rob Jones Ashish M. Kamat Vincent Khoo Anne E. Kiltie S. Krege Sylvain Ladoire Pedro C. Lara Anna M. Leliveld Estefanía Linares-Espinós Vibeke Løgager Anja Lorch Yohann Loriot Richard P. Meijer Maria Carmen Mir Marco Moschini Hugh Mostafid Arndt‐Christian Müller Christoph R. Müller James N’Dow Andrea Necchi Y. Neuzillet Jorg R. Oddens Jan Oldenburg Susanne Osanto Wim J.G. Oyen Luís Pacheco‐Figueiredo Helle Pappot Manish I. Patel Bradley R. Pieters Karin Plass Mesut Remzi Margitta Retz Jonathan Richenberg Michael Rink Florian Roghmann Jonathan E. Rosenberg Morgan Rouprêt Olivier Rouvière Carl Salembier Antti Salminen Paul Sargos

10.1016/j.eururo.2019.09.035 article EN European Urology 2019-11-20
Alan Horwich Marek Babjuk Joaquim Bellmunt H.M. Bruins Theo M. de Reijke and 95 more Maria De Santis Silke Gillessen Nicholas D. James Steven MacLennan Juan Palou Tom Powles María J. Ribal Shahrokh F. Shariat Theodorus H. van der Kwast Évanguelos Xylinas N. Agarwal T.J.H. Arends Aristotle Bamias Alison Birtle Peter C. Black Bernard H. Bochner M. Bolla Joost L. Boormans Alberto Bossi Alberto Briganti Iris Brummelhuis Max M. Burger Daniel Castellano Richard Cathomas Arturo Chiti Ananya Choudhury Éva Compérat Simon J. Crabb Stéphane Culine Berardino De Bari W. DeBlok Pieter J. L. De Visschere Karel Decaestecker Konstantinos Dimitropoulos J.L. Domínguez-Escrig Stefano Fanti Valérie Fonteyne Mark Frydenberg Jurgen J. Fütterer Georgios Gakis B. Geavlete Paolo Gontero Bernhard Grubmüller S. Hafeez Donna E. Hansel Arndt Hartmann Dickon Hayne Ann Henry Virginia Hernández H.W. Herr Ken Herrmann Peter Hoskin J. Huguet Barbara Alicja Jereczek‐Fossa Rob Jones Ashish M. Kamat Vincent Khoo Anne E. Kiltie S. Krege Sylvain Ladoire Pedro C. Lara Anna M. Leliveld Estefanía Linares-Espinós Vibeke Løgager Anja Lorch Yohann Loriot Richard P. Meijer Maria Carmen Mir Marco Moschini Hugh Mostafid Arndt‐Christian Müller C Müller James N’Dow Andrea Necchi Y. Neuzillet Jorg R. Oddens Jan Oldenburg Susanne Osanto Wim J.G. Oyen Luís Pacheco‐Figueiredo Helle Pappot Manish I. Patel Bradley R. Pieters Karin Plass Mesut Remzi Margitta Retz Jonathan Richenberg Michael Rink Florian Roghmann Jonathan E. Rosenberg Morgan Rouprêt Olivier Rouvière Carl Salembier Antti Salminen Paul Sargos

10.1093/annonc/mdz296 article EN publisher-specific-oa Annals of Oncology 2019-08-30
Susan van der Lei Robbert S. Puijk Madelon Dijkstra Hannah H. Schulz Danielle J. W. Vos and 90 more Jan J. J. de Vries Hester J. Scheffer Birgit I. Lissenberg‐Witte Luca Aldrighetti Mark J. Arntz Maarten W. Barentsz Marc G. Besselink B. Bracke Rutger C. G. Bruijnen Tineke E. Buffart Mark C. Burgmans T. Chapelle Mariëlle M.E. Coolsen Sanne de Boer Francesco De Cobelli Koert de Jong Johannes H.W. de Wilt Arjen L. Diederik Anniek M.C. Dooper Werner A. Draaisma Hasan H. Eker Joris I. Erdmann Jurgen J. Fütterer Bart Geboers Gerie Groot Jeroen Hagendoorn Henk H. Hartgrink Karin Horsthuis Rob Hurks Sjoerd F.M. Jenniskens Matthijs Kater Geert Kazemier Jakob W. Kist Joost M. Klaase Robrecht R M M Knapen Johan W. H. Kruimer Armand B G N Lamers Wouter K. G. Leclercq Gerrit‐Jan Liefers Eric R. Manusama Mark A. Meier Marleen C. A. M. Melenhorst J. Sven D. Mieog Q. Molenaar Karin Nielsen Maarten W. Nijkamp Vincent B. Nieuwenhuijs Irene M G C Nota Bart Op de Beeck Christiaan G. Overduin Gijs A. Patijn Fons H. Potters Francesca Ratti Floris J. Rietema Simeon J. S. Ruiter Evelien A. C. Schouten Wilhelmina H. Schreurs G Serafino Colin Sietses Gerrit D. Slooter Maarten L. J. Smits Ezgi A Soykan Gert-Jan Spaargaren Martijn W.J. Stommel Florentine E. F. Timmer Laurens J. van Baardewijk Ronald M. van Dam Otto M. van Delden Bente A. T. van den Bemd Janneke E. van den Bergh Peter B. van den Boezem Christiaan van der Leij R.W. van der Meer Bram B.M. van der Meijs Augustinus P. T. van der Ploeg J.J. van der Reijden Peter van Duijvendijk Arian R. van Erkel Anne M. van Geel N. Tjarda van Heek Christiaan J. van Manen Carla S. P. van Rijswijk Jan Hein T M van Waesberghe Kathelijn S. Versteeg Ted Vink I. Zijlstra Barbara M. Zonderhuis Rutger‐Jan Swijnenburg M. Petrousjka van den Tol Martijn R. Meijerink

10.1016/s1470-2045(24)00660-0 article EN The Lancet Oncology 2025-01-01

PURPOSE: To prospectively determine the accuracy of experienced and less readers in interpretation combined T2-weighted fast spin-echo (SE) magnetic resonance (MR) images dynamic contrast material–enhanced MR compared with SE alone, respect to differentiation stage T2 versus T3 prostate carcinoma, histologic analysis serving as reference standard. MATERIALS AND METHODS: Institutional review board approval informed consent were obtained, 124 consecutive men (age range, 42–74 years; median...

10.1148/radiol.2372041724 article EN Radiology 2005-11-01

We determined the positive and negative predictive values of multiparametric magnetic resonance imaging for extraprostatic extension at radical prostatectomy different prostate cancer risk groups.We evaluated a cohort 183 patients who underwent 3 Tesla imaging, including T2-weighted, diffusion weighted dynamic contrast enhanced sequences, with an endorectal coil before prostatectomy. Pathological stage was used as standard reference extension. The classified into low, intermediate high...

10.1016/j.juro.2013.05.021 article EN The Journal of Urology 2013-05-13
Coming Soon ...